The observation that cabozantinib treatment did not make MC38-CEA cells more sensitive to the cytotoxic effects of radiation (Additional file 1) suggests that cabozantinib’s alteration of the tumor cells is likely purely immunogenic. This evidence concerns the gene CEACAM5 and neoplasm.